Schwartz D M, Jumper M D, Lui G M, Dang S, Schuster S, Stern R
Beckman Vision Center, San Francisco, CA 94143-0730, USA.
Cornea. 1997 Mar;16(2):188-91.
The possible role of the human corneal endothelium in the turnover of anterior chamber hyaluronic acid (HA) was investigated. Hyaluronidase, an endoglycosidase that degrades HA and other glycosaminoglycans, is thought to play a role in HA homeostasis. The presence of hyaluronidase in the corneal endothelium was demonstrated immunohistochemically in sections from normal adult human cornea. Additionally, by using a modified enzyme-linked immunosorbent assay-like assay, active hyaluronidase was detected in the supernatant from primary culture human corneal endothelial cells. The optimal activity for the corneal endothelial hyaluronidase was in the acid range (pH 4.0), similar to previously isolated lysosomal hyaluronidase. Further immunohistochemistry showed that the corneal endothelial cells also express CD44, the receptor for HA, which would allow endocytosis of HA. Human corneal endothelial hyaluronidase may play a role in normal anterior segment HA metabolism and in the degradation of highly concentrated HA used as a visco-elastic.
研究了人角膜内皮细胞在前房透明质酸(HA)周转中的可能作用。透明质酸酶是一种能降解HA和其他糖胺聚糖的内切糖苷酶,被认为在HA的稳态中起作用。通过免疫组织化学方法在正常成人角膜切片中证实了角膜内皮细胞中存在透明质酸酶。此外,通过使用改良的类似酶联免疫吸附测定的方法,在原代培养的人角膜内皮细胞的上清液中检测到了活性透明质酸酶。角膜内皮透明质酸酶的最佳活性在酸性范围(pH 4.0),类似于先前分离的溶酶体透明质酸酶。进一步的免疫组织化学显示角膜内皮细胞也表达HA的受体CD44,这将允许HA的内吞作用。人角膜内皮透明质酸酶可能在正常眼前段HA代谢以及用作粘弹性物质的高浓度HA的降解中起作用。